Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ:307750)
South Korea · Delayed Price · Currency is KRW 2,235.00
+263.00 (13.34%)
At close: Jun 29, 2026
Kookjeon Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -7,849 | -4,299 | 1,736 | 4,824 | 8,948 | 4,038 |
Depreciation & Amortization | 5,250 | 5,227 | 5,105 | 3,134 | 1,444 | 1,106 |
Loss (Gain) From Sale of Assets | 25.3 | 25.3 | 57.43 | - | 69.18 | 0 |
Loss (Gain) From Sale of Investments | -548.91 | -285.19 | -1,831 | -16.28 | -373.28 | -0.86 |
Loss (Gain) on Equity Investments | 15.51 | 74.07 | 57.48 | -1.15 | 4.35 | 276.83 |
Provision & Write-off of Bad Debts | 136.94 | 1,408 | 13.63 | -9.72 | -3.06 | 113.92 |
Other Operating Activities | 7,492 | 1,882 | -628.32 | 2,130 | -9,299 | 753.65 |
Change in Accounts Receivable | 7,656 | 4,107 | -102.16 | -6,493 | -2,128 | -3,916 |
Change in Inventory | 3,240 | 7,963 | -105.88 | -7,203 | -3,541 | -3,813 |
Change in Accounts Payable | -7,310 | -6,466 | 5,716 | 3,406 | -670.22 | 5,448 |
Change in Other Net Operating Assets | 337.62 | 971.15 | -51.68 | -115.82 | -470.41 | -964.89 |
Operating Cash Flow | 8,446 | 10,608 | 9,967 | -345.45 | -6,019 | 3,042 |
Operating Cash Flow Growth | 15.09% | 6.44% | - | - | - | - |
Capital Expenditures | -3,919 | -3,114 | -7,867 | -43,923 | -23,285 | -10,409 |
Sale of Property, Plant & Equipment | 6.27 | 6.27 | 0.73 | - | 2.09 | - |
Cash Acquisitions | - | - | - | - | 295.92 | - |
Divestitures | - | - | - | 441 | - | - |
Sale (Purchase) of Intangibles | -35.95 | -69.83 | -3,622 | -157.99 | -482.07 | -8.8 |
Investment in Securities | 8,696 | -21,770 | 54,652 | 18,410 | -53,176 | -22,097 |
Other Investing Activities | 6.32 | 360.4 | -228.44 | 584.15 | 25.38 | 69.36 |
Investing Cash Flow | 4,824 | -24,517 | 42,796 | -24,314 | -76,633 | -32,579 |
Short-Term Debt Issued | - | 10,751 | 10,911 | 35,734 | 101,363 | 27,327 |
Long-Term Debt Issued | - | - | 42,827 | 8,000 | 18,562 | - |
Total Debt Issued | 12,882 | 10,751 | 53,739 | 43,734 | 119,925 | 27,327 |
Short-Term Debt Repaid | - | -28,920 | -69,335 | -28,338 | -33,395 | -33,653 |
Long-Term Debt Repaid | - | -9,177 | -845.01 | -1,690 | -933.22 | -293.8 |
Total Debt Repaid | -26,955 | -38,097 | -70,180 | -30,028 | -34,329 | -33,947 |
Net Debt Issued (Repaid) | -14,074 | -27,346 | -16,442 | 13,706 | 85,596 | -6,620 |
Issuance of Common Stock | 1,012 | 2,996 | - | - | - | 45,477 |
Repurchase of Common Stock | - | - | - | - | - | -1.03 |
Dividends Paid | - | -490.69 | -490.69 | - | -490.69 | - |
Other Financing Activities | -408.81 | -380 | 0 | 400 | -5.6 | -0 |
Financing Cash Flow | -13,470 | -25,221 | -16,932 | 14,106 | 85,100 | 38,856 |
Foreign Exchange Rate Adjustments | 0.85 | 0.74 | 0.69 | -0.26 | -0.34 | 0.13 |
Net Cash Flow | -199.18 | -39,130 | 35,831 | -10,554 | 2,447 | 9,320 |
Free Cash Flow | 4,527 | 7,494 | 2,100 | -44,269 | -29,304 | -7,367 |
Free Cash Flow Growth | 52.86% | 256.91% | - | - | - | - |
Free Cash Flow Margin | 3.55% | 5.72% | 1.54% | -36.29% | -28.26% | -8.63% |
Free Cash Flow Per Share | 90.09 | 150.30 | 42.33 | -902.17 | -571.94 | -167.01 |
Cash Interest Paid | 1,108 | 1,283 | 1,752 | 1,373 | 771.53 | 238.65 |
Cash Income Tax Paid | - | -93.52 | 746.06 | -115.43 | 1,625 | 518.27 |
Levered Free Cash Flow | -25.46 | -290.41 | -10,137 | -40,786 | -10,027 | - |
Unlevered Free Cash Flow | 2,935 | 2,934 | -4,999 | -37,202 | -8,901 | - |
Change in Working Capital | 3,924 | 6,576 | 5,456 | -10,406 | -6,809 | -3,245 |